EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Resensitizing drug-resistant cancers by co-targeting apoptosis and mitochondrial stress pathway

Ilnaz Rahimmanesh, Akbar Davoodi, Yujiao Chen, Franklin R Tay, Chandra Sekhar Bhol, Gautam Sethi, Pooyan Makvandi, Yi Xu

Drug Resistance Updates · 2026-09 · 88 · 101443

DOI: 10.1016/j.drup.2026.101443 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2026-09. Verfasst von Ilnaz Rahimmanesh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: Mitochondria, Drug Resistance, Neoplasm, Apoptosis, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 251 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Quzhou Municipal Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic resistance is a major barrier to durable cancer control in contemporary oncology practice. Despite extensive studies on individual cell death pathways and mitochondrial stress responses, a comprehensive framework describing how mitochondrial organization contributes to the coordination of multiple regulated cell death programs and therapeutic resistance remains insufficiently defined. This review examines resistance as malignant cells evade regulated cell death and adapt to mitochondrial stress. Mitochondria are framed as integrative hubs that link bioenergetics, redox regulation, metabolic flexibility, and stress signaling to apoptotic competence. It also describes how apoptosis connects with other death programs through mitochondrial compartmentalization. Signals from the matrix, inner membrane, and cristae, intermembrane space, and outer membrane influence ferroptosis, necroptosis, mitochondrial permeability transition-driven necrosis, and immunogenic cell death. Stress-response pathways are highlighted as interfaces between mitochondrial dysfunction and fate decisions, including the OMA1-DELE1-heme-regulated inhibitor kinase axis that activates the integrated stress response and ATF4-dependent transcription. Translationally, the review proposes a co-targeting framework that pairs apoptosis-directed therapies, especially BH3 mimetics, with interventions that destabilize mitochondrial homeostasis or tune stress signaling. Examples include electron transport chain inhibitors, integrated stress response modulators, and compartment-targeted strategies that alter cristae remodeling, calcium flux, or cardiolipin oxidation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaDrug Resistance, NeoplasmApoptosisNeoplasmsAntineoplastic AgentsHumansSignal TransductionAnimalsIntegrated Stress ResponseStress, PhysiologicalMetabolic Reprogramming

Stichwörter der Autor:innen

BCL-2 family regulationBH3 mimeticsIntegrated stress response (ISR)Mitochondrial stress signalingTherapeutic resistance

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Mathematics and Computer Science, University of Southern Denmark, 5230 Odense, Denmark.
  • Zhejiang University School of Medicine, Department of Physiology, Department of Cardiology of the Second Affiliated Hospital and School of Basic Medical Sciences & State Key Laboratory of Transvascular Implantation Devi…
  • Dental College of Georgia, Augusta University, Augusta, GA 30912, USA.
  • Department of Pharmacology and NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Singapore.
  • Department of Pharmacology and NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Singapore. Electronic address: phcgs@nus.edu.sg.

Förderung

  • National Natural Science Foundation of China
  • Quzhou Municipal Science and Technology Bureau

Zitieren

APA

Rahimmanesh, I., Davoodi, A., Chen, Y., Tay, F. R., Bhol, C. S., Sethi, G., Makvandi, P., & Xu, Y. (2026). Resensitizing drug-resistant cancers by co-targeting apoptosis and mitochondrial stress pathway. Drug Resistance Updates, 88, 101443. https://doi.org/10.1016/j.drup.2026.101443

Vancouver

Rahimmanesh I, Davoodi A, Chen Y, Tay FR, Bhol CS, Sethi G, et al. Resensitizing drug-resistant cancers by co-targeting apoptosis and mitochondrial stress pathway. Drug Resistance Updates. 2026;88:101443. doi:10.1016/j.drup.2026.101443

BibTeX
@article{Rahimmanesh2026,
  author = {Rahimmanesh, Ilnaz and Davoodi, Akbar and Chen, Yujiao and Tay, Franklin R and Bhol, Chandra Sekhar and Sethi, Gautam and Makvandi, Pooyan and Xu, Yi},
  title = {Resensitizing drug-resistant cancers by co-targeting apoptosis and mitochondrial stress pathway},
  journal = {Drug Resistance Updates},
  year = {2026},
  volume = {88},
  pages = {101443},
  doi = {10.1016/j.drup.2026.101443}
}
Kostenlos starten →